Home / Centerstage / 2015 / March / Week 2 /
Shareholders of Actavis PLC and Allergan Inc. approve Actavis's acquisition of Allergan. With a value of $66 billion, the deal is set to close in the second quarter, creating one of the world's largest pharmaceutical companies. The combined entity will have substantial sales, led by Allergan's popular antiwrinkle treatment Botox, and is expected to strengthen the companies' positions in the global market.
Monday, 9 March, 2015